Cannabis use disorder refers to problematic use of cannabis that results in clinically significant impairment, such as health, social, occupational, or legal problems. Cannabis contains a chemical compound called tetrahydrocannabinol (THC), which can impair judgement, motor coordination and cognitive function. Common treatment options for cannabis use disorder include psychotherapy, medication and support groups. Psychotherapy focuses on cognitive behavioral therapy (CBT) to help patients alter unhealthy behaviors and thinking patterns associated with cannabis misuse. Medications like naltrexone and acamprosate can reduce cravings to help patients stay in remission.



The global Cannabis Use Disorder treatment market is estimated to be valued at US$ 1.64 Billion in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period 2024-2031.

Increasing addiction rates and legalization of cannabis for medical use in various countries are major factors driving the demand for effective cannabis use disorder treatments.



Key Takeaways



Key players operating in the cannabis use disorder treatment market are Aelis Farma, Indivior, Pfizer, Corbus Pharmaceuticals, Zynerba Pharmaceuticals. Aelis Farma is currently evaluating the efficacy and safety of AEF02018, a novel synthetic cannabidiol compound, for treating cannabis use disorder. Indivior recently received FDA approval for Perseris (risperidone) to treat schizophrenia in adults. The company is now developing risperidone for treating cannabis-induced psychosis.



The global demand for cannabis use disorder treatment is rising due to increasing cannabis addiction rates, especially among young adults. According to a study, around 30% of users who first try cannabis during adolescence develop cannabis use disorder. With growing global acceptance of medical cannabis, the addiction rates are projected to rise further, thereby driving the need for advanced treatment options.



The global cannabis use disorder treatment market is also expanding due to rising research investments by leading pharmaceutical companies. Several candidates are under clinical trials to develop novel drugs with improved efficacy and safety. Furthermore, companies are also focusing on geographical expansion and availability of treatment services across countries where medical cannabis is legal. This is expected to significantly boost the market revenues during the forecast period.



Market Drivers



One of the major drivers of the cannabis use disorder treatment market is the increasing legalization of medical cannabis across countries. As of 2022, over 38 countries have legalized medical use of cannabis. This has increased accessibility and reduced the stigma associated with cannabis use. However, legalization has also led to a rise in cannabis addiction cases. This is creating a surge in demand for advanced medications and therapies to treat associated disorders like cannabis use disorder. Growing government support for research and development activities in this field will further aid the market expansion over the next few years.



The current geopolitical situations across various regions are impacting the growth of the Cannabis Use Disorder market. Political instability, regulatory changes around cannabis legalization and availability of treatment options vary widely between countries and regions. This creates challenges as well as opportunities for players operating in this market globally.



North America particularly the US currently presents the largest potential for cannabis use disorder treatment given states like Colorado and California have legalized recreational and medical cannabis use from several years. However, unpredictable policy changes at the federal level raises concerns. Recent moves towards legalizing medical use in several European countries like Germany is opening up new avenues for players here. Nonetheless, stricter rules and social acceptance issues in parts of Eastern Europe and Asia poses initial hurdles to market penetration in these territories.



The market value for Cannabis Use Disorder is highly concentrated in North America presently contributed by over 60% of the total worldwide share in 2024. This can be attributed to growing prevalence, clinical research proving efficacy of cannabis based formulations for withdrawal symptoms and availability of advanced treatment centres for substance abuse disorders. However, regions like Asia Pacific and Latin America are estimated to witness faster value growth during the forecast period owing to rising disposability income, aging population and gradual policy changes aiding accessibility to therapy options. Large patient pools in China and India indicate high commercialization prospective if social and cultural barriers are addressed properly.



The Latin American region especially Brazil and Mexico are identified as emerging hotspots for Cannabis Use Disorder treatment considering increasing government focus on mental health and substance dependence along with private sector investments in this area. Favorable regulations and popularity of botanical treatment systems can drive substantial gains for industry players catering to Latin America over the coming years through localized clinical research and culturally relevant marketing initiatives.



Understanding variances in regional disease landscapes, local socio-economic parameters as well as political willingness is key for businesses in the Cannabis Use Disorder market to devise successful long term strategies. They need to explore potential synergies through strategic partnerships, product customization, establishing manufacturing presence and raising awareness to capture diverse geographical markets as legal and social scenarios evolve worldwide.

Get more insights on this topic : https://medium.com/@pragajitank24/cannabis-use-disorder-market-is-estimated-to-witness-high-growth-owing-to-growing-cannabidiol-3861b7448e01

What Are The Key Data Covered In This Cannabis Use Disorder  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Cannabis Use Disorder 's growth between 2024 and 2031.

:- Accurate calculation of the size of the Cannabis Use Disorder  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Cannabis Use Disorder  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Cannabis Use Disorder  vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:

1. Source: Coherent Market Insights, Public sources, Desk research

2. We have leveraged AI tools to mine information and compile it